An Open-label Study of a Gene Therapy Product (Vebeglogene Autotemcel) in Transfusion Dependent Beta-Thalassemia
Clinical trial NCT06308159 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06308159
- Sponsor
- Lantu Biopharma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-11
- Primary completion
- 2027-08-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.